Filtros de búsqueda

Lista de obras de

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

artículo científico publicado en 2019

Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?

artículo científico publicado en 2020

Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort

scientific article published on 24 January 2019

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

artículo científico publicado en 2011

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

artículo científico publicado en 2015

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

artículo científico publicado en 2010

Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study

artículo científico publicado en 2017

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection

artículo científico publicado en 2014

Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir

artículo científico publicado en 2016

Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?

artículo científico publicado en 2019

Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations

scientific article published on 22 August 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda